Analyst Price Targets — HCC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 30, 2026 12:28 pm | — | UBS | $100.00 | $81.57 | TheFly | Warrior Met Coal price target lowered to $100 from $102 at UBS |
| March 27, 2026 1:14 pm | George Eadie | UBS | $105.00 | $99.16 | TheFly | Warrior Met Coal price target raised to $105 from $101 at UBS |
| January 29, 2026 9:50 am | — | UBS | $108.00 | $90.09 | TheFly | Warrior Met Coal upgraded to Buy from Neutral at UBS |
| January 20, 2026 1:49 pm | — | Jefferies | $120.00 | $99.27 | TheFly | Warrior Met Coal price target raised to $120 from $95 at Jefferies |
| December 12, 2025 1:17 pm | George Eadie | UBS | $86.00 | $82.46 | TheFly | Warrior Met Coal price target raised to $86 from $80 at UBS |
| November 24, 2025 11:21 am | — | UBS | $80.00 | $75.07 | TheFly | Warrior Met Coal price target raised to $80 from $75 at UBS |
| October 8, 2025 12:41 pm | — | UBS | $68.00 | $63.88 | TheFly | Warrior Met Coal price target raised to $68 from $60 at UBS |
| August 7, 2025 11:43 am | Katja Jancic | BMO Capital | $55.00 | $58.73 | StreetInsider | Warrior Met Coal (HCC) PT Raised to $55 at BMO Capital |
| August 3, 2022 8:29 pm | David Gagliano | BMO Capital | $37.00 | $31.52 | TheFly | Warrior Met Coal downgraded to Market Perform from Outperform at BMO Capital |
Latest News for HCC
BROOKWOOD, Ala.--(BUSINESS WIRE)--Warrior Met Coal, Inc. (“Warrior” or NYSE: HCC) today announced that it will hold its second quarter 2026 investor conference call at 4:30 p.m. ET on Wednesday, August 5, 2026. Warrior will release its results following the close of market trading that afternoon. To participate in the conference call, please call 1-844-340-9047 (domestic) or 1-412-858-5206 (international) 10 minutes…
Transaction expected to provide HCC Healthcare with access to public capital markets to accelerate growth in integrated medical and long-term care services across Asia Transaction expected to provide HCC Healthcare with access to public capital markets to accelerate growth in integrated medical and long-term care services across Asia
TriSalus Life Sciences, Inc. (Nasdaq: TLSI), an oncology company integrating novel delivery technology with standard-of-care therapies and an investigational i
On June 09, 2026, Warrior Met Coal Inc (HCC) shares fell 4.3% to a current price of $94.67, continuing a downward trend noted over the past week with a decline
[url="]Exelixis, Inc.[/url] (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal trial, which showed that CABOMETYXÂ
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
No House trades found for HCC.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.